about
Genetic variation of hepatitis B virus and its significance for pathogenesisThe expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infectionStructural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccinesInduced immunity against hepatitis B virusT-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significanceImmune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DPEnchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replicationDNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.Virologic and biochemical responses to clevudine in patients with chronic HBV infection-associated cirrhosis: data at week 48.Hepatitis B Virus Immunopathology, Model Systems, and Current TherapiesContribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.Association of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection.MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic InfectionVitamins in the treatment of chronic viral hepatitis.Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infectionClinical features and outcome of acute hepatitis B in pregnancy.A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis BImmunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection.Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in miceFactors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patientsSerum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfaVirus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection.Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression.Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy.Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice.Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis.Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infectionDirect observation of nanoparticle-cancer cell nucleus interactions.Lack of Association between Polymorphisms of the TLR4 Gene and Infection with the Hepatitis B and C VirusesThe Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies.
P2860
Q26772348-B4D0729F-8345-4BA6-9FB7-4576E6C7444AQ27316653-2AA3E57C-42A7-4FA7-B006-98D52C7BE96AQ27667663-53C6635D-424A-4039-8186-DFA55F77A3ACQ28080525-8FEF6129-CD59-4F24-961E-E0813D768F01Q28083810-C7E84C40-0038-45E4-9AC0-CE44176E58F2Q28086834-6D7EA0C4-09FE-4C9F-B5D3-BA0A6768C5D5Q28740406-6D1A2871-C067-4CC7-91BC-09166C0DA668Q31028199-CFF2FD20-B1A1-4B51-B977-B559C13D707FQ33370720-BCF1014E-A25D-4736-817C-C5D88DA65D6AQ33549555-82856E98-1A58-4619-8499-BE25E37C91E3Q33559657-DAA44B1F-B095-44ED-8A6A-6346AC3C2B30Q33680736-6138386E-2657-4238-BE1D-6820929A9BEDQ33683128-F1BFBEDE-8159-4C62-A4F4-2472F98B2495Q33705688-277F3B93-C7E9-489A-8269-8D0B5061774EQ33757923-C74933DE-F9DE-4CE3-8A80-A7FDEDD04B24Q33800048-07DB01A6-1F69-4F59-A0F3-1313226A75DEQ33808113-D5DC7EC5-FBAB-40FD-A5E3-C60DEE281122Q33896602-45590618-2148-4A76-BE3C-C4AA04448EB8Q33933196-9BC670C7-3DED-4C3A-95EC-2E58D8787D63Q33959352-B85CFA19-0EC8-40A5-9BD4-43E8FFD2E204Q33959861-59A28625-1F34-4BF0-8DD7-B424E10643BFQ34064400-F5BAA277-2563-478E-A837-AAE2139E9EF6Q34099008-9A267C4F-B8C2-443C-ACCF-30E4EDE16986Q34168451-99285C94-99D7-4143-9F83-F9762749205DQ34294206-7C7322F8-AE3C-44B9-A8BA-1C9F5934C833Q34556199-A4DB8AD9-B303-4964-9443-FA2B14FE5002Q34764269-4BD84FC7-E77D-460B-8EB4-77A9E7ADB021Q34866687-F13EC6A0-F8BF-4241-B9D4-DD44424E606AQ34922094-4D698A22-ED91-49F8-9CAB-7424DA773390Q34975716-BAF9642D-9728-4C17-8A73-34F0470AB341Q35008279-C79DB8C1-8F8E-4A1F-906B-28178AC3C52FQ35372981-7ED75865-3E9C-4D8D-AC2F-044B18B4DFF9Q35582436-41EBAAC6-28EF-45DB-B613-C03247D02B56Q35590251-50B66919-B60A-4A4D-817A-C45685FFC943Q35616664-625BEA20-D4F9-4A85-B0B4-F43F1293831FQ35866293-FDD87685-5A37-498E-9845-D2B709E42A13Q35868037-7524CB1B-161B-447D-8970-CB20B2EE4FADQ35914639-D57C78C5-F5FB-472A-B8FE-F0EC23446656Q35980718-2737D469-9BD6-4550-976E-07F1E08623F4Q36038914-4531DF4C-654D-4335-8AFE-7077CFAAA957
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The immune response during hepatitis B virus infection.
@ast
The immune response during hepatitis B virus infection.
@en
type
label
The immune response during hepatitis B virus infection.
@ast
The immune response during hepatitis B virus infection.
@en
prefLabel
The immune response during hepatitis B virus infection.
@ast
The immune response during hepatitis B virus infection.
@en
P356
P1476
The immune response during hepatitis B virus infection.
@en
P2093
Adam J Gehring
P304
P356
10.1099/VIR.0.81920-0
P407
P577
2006-06-01T00:00:00Z